PARIS--(BUSINESS WIRE)--Regulatory News: ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully ...
The company appoints Joel Parker, Ph.D., as Chief Scientific Officer; Ana Vivancos, Ph.D., as Director of NGS and Genomic Technologies; and Aleix Prat, M.D., Ph.D., as Chairman of the Board of ...
Guided by the motto "Next Generation Cancer Diagnostics”, ALIKO SCIENTIFIC embodies the Group’s renewed vision and its commitment to revolutionize cancer detection and treatment. By integrating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results